isoflavone Report issue

Botanical Experimental
AACT DrugBank PubChem

Active Ingredient History

NOW
  • Now
Isoflavones are substituted derivatives of isoflavone, a type of naturally occurring isoflavonoids, many of which act as phytoestrogens in mammals. Isoflavones are produced almost exclusively by the members of the bean family, Fabaceae (Leguminosae).   Wikipedia

Chemistry

  • SMILES: O=c1c(-c2ccccc2)coc2ccccc12
  • InChIKey: GOMNOOKGLZYEJT-UHFFFAOYSA-N
  • Mol. Mass: 222.24
  • ALogP: 3.46
  • ChEMBL Molecule:
    isoflavone  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Alternative names

isoflavona | isoflavone | isoflavones | novasoy | rimostil

Organizations (32)

Research & Development (32)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (15)

Approved Indications (1)


 

Respiratory Tract Diseases

Experimental Indications - Clinical Trial Phases 1-4 (14)


 

Alzheimer Disease (Phase 2)

Atrophy (Phase 2)

Breast Neoplasms (Phase 2)

Climacteric (Phase 3)

Depression (Phase 4)

Diabetes, Gestational (Early Phase 1)

Flushing (Phase 2)

Hot Flashes (Phase 4)

Memory Disorders (Phase 2)

Menopause (Phase 3)

Neoplasms ()

Pelvic Floor (Phase 4)

Postmenopause (Phase 3)

Prostatic Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 26
  • # of Trial Organizations: 32

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue